ALB and hepatocellular carcinoma: A study conducted by Carling et al. [116] ascertained that a high pre-treatment serum PLT–ALB–BIL grade was independently associated with worse OS in HCC patients treated with drug-eluting embolic TACE (DEE-TACE).